X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8) 8
index medicus (8) 8
multiple myeloma (7) 7
hematology, oncology and palliative medicine (6) 6
multiple myeloma - drug therapy (6) 6
oncology (6) 6
female (5) 5
aged (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
care and treatment (4) 4
male (4) 4
treatment outcome (4) 4
adult (3) 3
bortezomib (3) 3
drug administration schedule (3) 3
drug dosages (3) 3
kaplan-meier estimate (3) 3
lenalidomide plus dexamethasone (3) 3
middle aged (3) 3
multiple myeloma - pathology (3) 3
plasma (3) 3
product development (3) 3
prognosis (3) 3
proteins (3) 3
risk factors (3) 3
stem-cell transplantation (3) 3
therapy (3) 3
transplants & implants (3) 3
antineoplastic agents - adverse effects (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
bone marrow (2) 2
boronic acids - administration & dosage (2) 2
chemotherapy (2) 2
dexamethasone (2) 2
dexamethasone - administration & dosage (2) 2
diagnosis (2) 2
disease-free survival (2) 2
dose-response relationship, drug (2) 2
drug therapy (2) 2
drugs (2) 2
hematology (2) 2
immunomodulation (2) 2
internal medicine (2) 2
medical colleges (2) 2
medicine (2) 2
multicenter (2) 2
multiparameter flow-cytometry (2) 2
multiple myeloma - diagnosis (2) 2
multiple myeloma - mortality (2) 2
neoplasm recurrence, local - drug therapy (2) 2
patients (2) 2
positron-emission-tomography (2) 2
prednisone (2) 2
proteasome inhibitors (2) 2
pyrazines - administration & dosage (2) 2
risk (2) 2
risk assessment (2) 2
spain (2) 2
steroids (2) 2
studies (2) 2
survival (2) 2
thalidomide (2) 2
thalidomide - administration & dosage (2) 2
transplantation (2) 2
urine (2) 2
abdominal fat - drug effects (1) 1
abdominal fat - metabolism (1) 1
abridged index medicus (1) 1
acids (1) 1
adipose tissue (1) 1
administration, oral (1) 1
age factors (1) 1
aged patients (1) 1
aged, 80 and over (1) 1
analysis (1) 1
androgen excess (1) 1
androgens (1) 1
anemia (1) 1
angiogenesis inhibitors (1) 1
angiogenesis inhibitors - administration & dosage (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antibodies, monoclonal - adverse effects (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic agents, alkylating - administration & dosage (1) 1
antitumor activity (1) 1
antitumor-activity (1) 1
applied chemistry (1) 1
arteriosclerosis (1) 1
asthma (1) 1
atherosclerosis (1) 1
autografts (1) 1
binding sites (1) 1
biochemistry (1) 1
biological products (1) 1
biology (1) 1
biomarkers (1) 1
biomarkers - metabolism (1) 1
biomarkers, tumor (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 8, pp. e328 - e346
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10027, pp. 1551 - 1560
Summary Background New treatment options are needed for patients with multiple myeloma that is refractory to proteasome inhibitors and immunomodulatory drugs.... 
Internal Medicine | SURVIVAL | MEDICINE, GENERAL & INTERNAL | RISK | MULTICENTER | THERAPY | ELOTUZUMAB | Drug Administration Schedule | United States | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Kaplan-Meier Estimate | Neoplasm Recurrence, Local - drug therapy | Antibodies, Monoclonal - therapeutic use | Drug Resistance, Neoplasm | Male | Treatment Outcome | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Spain | Canada | Disease-Free Survival | Multiple Myeloma - drug therapy | Antibodies, Monoclonal - administration & dosage | Antineoplastic Agents - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adult | Female | Aged | Drugs | Medical colleges | Biological products | Multiple myeloma | Monoclonal antibodies | Product development | Lymphomas | Drug therapy | Care and treatment | Analysis | Studies | Protease inhibitors | Hematology | Stem cells | Cytotoxicity | Patients | Drug dosages | Slopes | Therapy | Schedules | Intravenous administration | Stem cell transplantation | Transplantation | Drug screening | Immunosuppressive agents | Randomization | CD38 antigen | Autografts | Anemia | Immunomodulation | Research & development--R&D | FDA approval | Survival | Proteasome inhibitors | Asthma | Refractory materials | Inhibitors | Interactive systems | Response rates
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 11, pp. 1195 - 1206
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 12, pp. e538 - e548
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 10, pp. 934 - 941
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2011, Volume 6, Issue 12, p. e29052
Polycystic ovary syndrome (PCOS) is a variable disorder characterized by a broad spectrum of anomalies, including hyperandrogenemia, insulin resistance,... 
PLACEBO | ANDROGEN EXCESS | PLASMA | MULTIDISCIPLINARY SCIENCES | LOW-DENSITY-LIPOPROTEIN | CARDIOVASCULAR-DISEASE | RATS | LOW-DOSE PIOGLITAZONE | RISK | IDENTIFICATION | YOUNG-WOMEN | Multivariate Analysis | Polycystic Ovary Syndrome - blood | Metformin - therapeutic use | Linoleic Acid - metabolism | Humans | Chromatography, Gas | Thiazolidinediones - administration & dosage | Dose-Response Relationship, Drug | Young Adult | Thiazolidinediones - therapeutic use | Polycystic Ovary Syndrome - drug therapy | Spectrometry, Mass, Electrospray Ionization | Lipoproteins - metabolism | Oxidation-Reduction - drug effects | Chromatography, Liquid | Female | Dicarboxylic Acids - blood | Metformin - administration & dosage | Drug Therapy, Combination | Flutamide - therapeutic use | Thiazolidinediones - pharmacology | Biomarkers - metabolism | Polycystic Ovary Syndrome - metabolism | Magnetic Resonance Spectroscopy | Carotid Intima-Media Thickness | Health | Metformin - pharmacology | Linoleic Acid - chemistry | Abdominal Fat - drug effects | Metabolomics - methods | Flutamide - pharmacology | Abdominal Fat - metabolism | Flutamide - administration & dosage | Obesity | Androgens | Flutamide | Blood cholesterol | Stein-Leventhal syndrome | Low density lipoproteins | Atherosclerosis | Insulin resistance | Oxidation-reduction reaction | Hypoglycemic agents | Lipoproteins (low density) | Metabolomics | Adipose tissue | Biomedical research | Nuclear magnetic resonance--NMR | Medical services | Dyslipidemia | Metabolic syndrome | Metabolites | Physiology | Oxidation | Lipoproteins (high density) | Drug dosages | Hypertension | Polycystic ovary syndrome | Internal medicine | Pioglitazone | Markers | Health risks | Particulates | Insulin | Low density lipoprotein | Cholesterol | Endothelium | Acids | Arteriosclerosis | Pharmacy | Metformin | Diabetes | Cardiovascular diseases | Endocrinology | Metabolic disorders | Metabòlits | Ovary diseases | Malalties de l'ovari | Nuclear magnetic resonance | NMR
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.